We are live on ! Find out more
CA

Claris Advisors Portfolio holdings

AUM $383M
1-Year Est. Return 27.62%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+27.62%
3 Year Est. Return
+65.72%
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
+$36.5M
Cap. Flow
+$22.7M
Cap. Flow %
9.86%
Top 10 Hldgs %
74.6%
Holding
1,236
New
1,180
Increased
40
Reduced
6
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 1.91%
2 Technology 1.89%
3 Industrials 1.6%
4 Healthcare 1.33%
5 Consumer Discretionary 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCPC
776
Balchem Corp
BCPC
$5.29B
$352 ﹤0.01%
+2
New +$341
SUM
777
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$351 ﹤0.01%
+9
New +$346
CADE
778
DELISTED
Cadence Bank
CADE
$350 ﹤0.01%
+11
New +$341
HOG icon
779
Harley-Davidson
HOG
$2.61B
$347 ﹤0.01%
+9
New +$326
WTRG icon
780
Essential Utilities
WTRG
$11.2B
$347 ﹤0.01%
+9
New +$354
FCFS icon
781
FirstCash
FCFS
$9.06B
$344 ﹤0.01%
+3
New +$340
OZK icon
782
Bank OZK
OZK
$5.5B
$344 ﹤0.01%
+8
New +$341
PANW icon
783
Palo Alto Networks
PANW
$259B
$342 ﹤0.01%
+2
New +$337
SANM icon
784
Sanmina
SANM
$11.2B
$342 ﹤0.01%
+5
New +$345
WD icon
785
Walker & Dunlop
WD
$1.69B
$341 ﹤0.01%
+3
New +$314
FNB icon
786
FNB Corp
FNB
$6.71B
$339 ﹤0.01%
+24
New +$343
KAI icon
787
Kadant
KAI
$3.69B
$338 ﹤0.01%
+1
New +$319
HLNE icon
788
Hamilton Lane
HLNE
$3.83B
$337 ﹤0.01%
+2
New +$290
BIO icon
789
Bio-Rad Laboratories Class A
BIO
$8.47B
$335 ﹤0.01%
+1
New +$318
CBT icon
790
Cabot Corp
CBT
$4.61B
$335 ﹤0.01%
+3
New +$299
DXCM icon
791
DexCom
DXCM
$28.3B
$335 ﹤0.01%
+5
New +$411
JAZZ icon
792
Jazz Pharmaceuticals
JAZZ
$16B
$334 ﹤0.01%
+3
New +$329
RH icon
793
RH
RH
$3.4B
$334 ﹤0.01%
+1
New +$275
UBSI icon
794
United Bankshares
UBSI
$6.57B
$334 ﹤0.01%
+9
New +$328
COLM icon
795
Columbia Sportswear
COLM
$3.25B
$333 ﹤0.01%
+4
New +$321
FMC icon
796
FMC
FMC
$1.39B
$330 ﹤0.01%
+5
New +$306
OGE icon
797
OGE Energy
OGE
$10.2B
$328 ﹤0.01%
+8
New +$310
SON icon
798
Sonoco
SON
$5.8B
$328 ﹤0.01%
+6
New +$314
BWA icon
799
BorgWarner
BWA
$13.1B
$327 ﹤0.01%
+9
New +$297
CRVL icon
800
CorVel
CRVL
$3.08B
$327 ﹤0.01%
+3
New +$300

Similar funds

Claris Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Claris Advisors held 1,236 positions worth $231M, up 19% from $194M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Claris Advisors deployed $22.7M of net new capital in Q3 2024, opening 1,180 new positions and adding to 40 existing holdings. Its largest new stake was Eli Lilly: 665 shares worth $589K.

By sector, the portfolio is most concentrated in Financials at 1.9% of assets, up from 1.3% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dimensional US Core Equity Market ETF, an estimated $94.3K trimmed.

  • Claris Advisors's largest Q3 2024 buy was Eli Lilly: 665 shares worth $589K.
  • Claris Advisors added most to Dimensional US Core Equity 2 ETF in Q3 2024, an estimated $1.99M increase.
  • Claris Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $94.3K.
  • Claris Advisors fully exited Caleres in Q3 2024, selling an estimated $443K.
  • Claris Advisors's ten largest holdings make up 75% of its $231M portfolio in Q3 2024.
  • Claris Advisors opened 1,180 new positions and closed 1 in Q3 2024.
  • Claris Advisors's portfolio value rose 19% quarter-over-quarter to $231M.

Based on Claris Advisors's 13F filing for Q3 2024, filed 31 Oct 2024.